These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4024860)

  • 21. Aspirin dose in prevention of transient ischaemic attacks.
    Olsson JE
    Lancet; 1979 Apr; 1(8120):830. PubMed ID: 86079
    [No Abstract]   [Full Text] [Related]  

  • 22. [Secondary prevention with clopidogrel after TIA or stroke].
    Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
    Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke.
    Redman AR; Ryan GJ
    Clin Ther; 2001 Sep; 23(9):1391-408. PubMed ID: 11589255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study.
    Petty GW; Brown RD; Whisnant JP; Sicks JD; O'Fallon WM; Wiebers DO
    Ann Intern Med; 1999 Jan; 130(1):14-22. PubMed ID: 9890845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet drugs in secondary prevention of stroke.
    Diener HC
    Int J Clin Pract; 1998 Mar; 52(2):91-7. PubMed ID: 9624789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event.
    Sivenius J; Riekkinen PJ; Lowenthal A; Smets P; Laakso M
    Arch Neurol; 1993 Jul; 50(7):710-3. PubMed ID: 8323473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks.
    Matías-Guiu J; Dávalos A; Picó M; Monasterio J; Vilaseca J; Codina A
    Acta Neurol Scand; 1987 Dec; 76(6):413-21. PubMed ID: 3324618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Moonis M; Fisher M
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260
    [No Abstract]   [Full Text] [Related]  

  • 35. [Transient ischemic attacks and prolonged reversible ischemic neurologic deficit. Diagnosis, differential diagnosis and treatment].
    Mosso M; Baumgartner RW
    Praxis (Bern 1994); 2000 Mar; 89(13):542-8. PubMed ID: 10776056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke.
    Douen AG; Medic S; Sabih M; Pageau N; Shuaib A
    J Stroke Cerebrovasc Dis; 2008; 17(6):356-9. PubMed ID: 18984426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of vascular events after transient ischemic attack or cerebral infarct].
    Leys D; Cordonnier C
    Rev Prat; 2006 Sep; 56(13):1437-42. PubMed ID: 17002069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.
    Bellavance A
    Stroke; 1993 Oct; 24(10):1452-7. PubMed ID: 8378945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The European Stroke Prevention Study: results according to sex.
    Sivenius J; Laakso M; Penttilä IM; Smets P; Lowenthal A; Riekkinen PJ
    Neurology; 1991 Aug; 41(8):1189-92. PubMed ID: 1866002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
    Gibbs CR; Li-Saw-Hee FL; Lip GY
    Scott Med J; 1998 Feb; 43(1):6. PubMed ID: 9533251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.